Healthcare

UPDATE 1-Dynavax stops development of allergy drug, shares fall 8:19am EDT

May 16 (Reuters) - Dynavax Technologies Corp said it would stop developing its experimental ragweed allergy drug, Tolamba, after it failed to meet the main goal of a mid-stage clinical trial, sending its shares down more than 7 percent. Full Article

TAKE-A-LOOK-Clinical Oncology annual meeting 8:07am EDT

The American Society of Clinical Oncology released a wave of abstracts of clinical studies on Thursday ahead of its annual meeting. The official meeting, a premier scientific and medical event in the oncology community, begins on May 30 in Chicago. Full Article

UPDATE 1-SAfrica's Medi-Clinic full year earnings up 5 pct 7:15am EDT

JOHANNESBURG, May 16 (Reuters) - South African hospital group Medi-Clinic said on Friday its full-year headline earnings rose by 5 percent to 608 million rand ($80.49 million) for the year to March. Full Article

More Healthcare Articles

Total still targets Sanofi stake sale but no hurry 7:04am EDT

PARIS, May 16 (Reuters) - Total remains determined to sell its 13-percent stake in French pharmaceuticals group Sanofi-Aventis but is in no hurry to do so for the moment given Sanofi's weak share price, the French oil company said on Friday. Full Article

UK's Antisoma paying $52 mln for U.S. cancer firm 6:59am EDT

LONDON, May 16 (Reuters) - British biotechnology company Antisoma Plc agreed to buy Xanthus Pharmaceuticals Inc, a private U.S. cancer specialist, for 26.8 million pounds ($52.2 million) in shares, it said on Friday. Full Article

U.N. experts to say 2010 biodiversity target elusive 7:10am EDT

BERLIN (Reuters) - Nearly 200 governments will say next week they are unlikely to meet a target of slowing the rate of extinctions of living species by 2010, a failure which could threaten future food supplies. Full Article

SAfrica's Medi-Clinic full year earnings up 5 pct 6:51am EDT

JOHANNESBURG, May 16 (Reuters) - South African hospital group Medi-Clinic said on Friday its full year headline earnings rose by 5 percent to 608 million rand ($80.49 million) for the year to March. Full Article

Sanofi shares gain on hopes for heart drug sales 3:26am EDT

LONDON (Reuters) - Sanofi-Aventis shares rose around 3 percent on Friday as investors welcomed positive clinical trial results for heart drug Multaq, which some analysts believe could sell more than $2 billion a year. Full Article

S.Africa's Netcare names Jerry Vilakazi as chairman 3:15am EDT

JOHANNESBURG, May 16 (Reuters) - Africa's largest private hospital group Netcare said on Friday it had appointed Jerry Vilakazi as independent non-executive chairman with effect from June 1. Full Article

Bioton Q1 net down 66 percent on financial costs 1:47am EDT

WARSAW, May 16 (Reuters) - Polish bio-pharmaceutical company Bioton reported a 66 percent drop in earnings on jumping financial costs, the company said late on Thursday. Full Article

Market Update

Exchanges and Trading Summit

Execs defend humans in high-tech markets Friday, 9 May 2008 08:04pm EDT

NEW YORK (Reuters) - The heads of the world's biggest stock exchanges agree there is still room for the "human element" in a high-speed trading environment that has aggressively gone electronic. Full Article

NASDAQ OMX backs Paulson rules blueprint

New trading platforms challenge LSE